Language: 简体中文 English
Welcome Message
Immunotherapy is changing the treatment paradigm for many types of cancer, with a number of checkpoint blockers and the first cellular therapies on the market. Beyond cancer, immunotherapeutic approaches are undergoing clinical trials for autoimmune conditions and infectious diseases. This Nature conference brings together leading experts from around the globe to discuss a range of immunotherapeutic approaches and the immunological basis that informs these efforts. Besides covering immune checkpoint inhibitors and cellular therapies, sessions will explore vaccination approaches and oncolytic therapy, the role of innate immune cells and their potential for immunotherapy, the effect of the microbiota on immunotherapy and how to exploit immunometabolism to modulate immune responses in cancer and beyond.
  • DAYS
Key Dates
      June 11-13, 2019

      Early Registration Deadline
      March 31, 2019

      Abstract Submission Deadline
      May 15, 2019

      On-line Registration Deadline
      June 3, 2019

      On-site Registration Date
      June 11, 2019

Contact Us

Contact for General Information  
Gang Liu:

Contact for Organization
Wei Wei
Contact for hotel
Juan Kang:

Technical Support   
Zhubo Chen: